Benzodiazepine and Z-drug use and risk of pneumonia in patients with chronic kidney disease: A population-based nested case-control study.

Meng-Ting WangYun-Han WangHsin-An ChangChen-Liang TsaiYa-Sung YangChen Wei LinCheng-Chin KuoYu-Juei Hsu

Published in: PloS one (2017)

Use of BZRAs is associated with an increased risk of pneumonia in CKD patients, especially for patients newly initiating BZDs or Z-drugs or those injected with BZDs. Physicians should exercise cautions for signs of pneumonia when prescribing BZDs or Z-drugs to CKD patients.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
patient reported
body composition
electronic health record
acute respiratory distress syndrome
resistance training